Skip to content

Clinical trials

Phase 2 Respiratory Tract Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 2 Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20071
20082
20095
20105
20115
20125
20134
20145
20152
20162
20174
20183
20194
20206
20212
20223
20234
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed47
Terminated9
Withdrawn5
Active, not recruiting4
Unknown status3
Suspended1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicago6
Pfizer6
Cardeas Pharma2
Insmed Incorporated2
Queen Mary University of London2
Seqirus2
ADMA Biologics, Inc.1
Afexa Life Sciences Inc1
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.1
Altesa Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections70
Respiratory Tract Diseases21
Virus Diseases20
Influenza, Human15
Infections13
RNA Virus Infections12
Orthomyxoviridae Infections10
COVID-197
Lung Diseases7
Pneumonia7

Trials

Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.